Jingxia Du
Impact in
- Ophthalmology top 5%
- Retinal Diseases and Treatments
Papers in
-
- Metabolism, Diabetes, and Cancer 2
- CRISPR and Genetic Engineering 2
-
- Adipokines, Inflammation, and Metabolic Diseases 3
- Co-authors
- Gaofeng Liang (8 shared papers)Shuying Feng (6 shared papers)Manhui Zhu (3 shared papers)E Song (3 shared papers)Aifang Li (4 shared papers)Xiaodong Sun (2 shared papers)Xun Xu (2 shared papers)Man‐Wen Jin (3 shared papers)
- Journals
- Journal of Biomedical Nanotechnology (1 paper)Pharmaceutics (1 paper)ACS Infectious Diseases (1 paper)Experimental Eye Research (1 paper)BioMed Research International (1 paper)
- Partner nations
- ChinaUnited States
In The Last Decade
Jingxia Du
21 papers receiving 475 citations
Peers
Comparison fields: 5 of 80
- Ophthalmology 73
- Geriatrics and Gerontology 19
- Neurology 39
- Clinical Biochemistry 32
- Biochemistry 22
Countries citing papers authored by Jingxia Du
This map shows the geographic impact of Jingxia Du's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jingxia Du with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jingxia Du more than expected).
Fields of papers citing papers by Jingxia Du
This network shows the impact of papers produced by Jingxia Du. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jingxia Du. The network helps show where Jingxia Du may publish in the future.
Co-authors
The 25 scholars most cited alongside Jingxia Du, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 51 | |
| 2 | 2019 | 45 | |
| 3 | 2020 | 44 | |
| 4 | 2022 | 37 | |
| 5 | 2021 | 33 | |
| 6 | 2020 | 33 | |
| 7 | 2020 | 30 | |
| 8 | 2019 | 28 | |
| 9 | 2020 | 24 | |
| 10 | 2017 | 20 | |
| 11 | 2014 | 20 | |
| 12 | 2020 | 19 | |
| 13 | 2024 | 17 | |
| 14 | 2020 | 17 | |
| 15 | 2024 | 13 | |
| 16 | 2019 | 11 | |
| 17 | 2016 | 10 | |
| 18 | 2018 | 9 | |
| 19 | 2019 | 9 | |
| 20 | 2022 | 7 |
About Jingxia Du
Jingxia Du is a scholar working on Molecular Biology, Epidemiology, Physiology, Cardiology and Cardiovascular Medicine and Ophthalmology, having authored 21 papers that have together received 481 indexed citations. Recurring topics across this work include Adipose Tissue and Metabolism (3 papers), Retinal Diseases and Treatments (3 papers), Adipokines, Inflammation, and Metabolic Diseases (3 papers), MicroRNA in disease regulation (2 papers), Metabolism, Diabetes, and Cancer (2 papers), Aquaculture disease management and microbiota (2 papers), CRISPR and Genetic Engineering (2 papers) and Cardiovascular Function and Risk Factors (2 papers). The work is most often cited by research in Ophthalmology (73 citations), Geriatrics and Gerontology (19 citations), Neurology (39 citations), Clinical Biochemistry (32 citations) and Biochemistry (22 citations). Jingxia Du has collaborated with scholars based in China and United States. Frequent co-authors include Gaofeng Liang, Shuying Feng, Manhui Zhu, E Song, Aifang Li, Xiaodong Sun, Xun Xu, Man‐Wen Jin, Lina Hu and Jia Zhao. Their work appears in journals such as Journal of Biomedical Nanotechnology, Pharmaceutics, ACS Infectious Diseases, Experimental Eye Research and BioMed Research International.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.